SLP · As filed with the SEC
Simulations Plus cash flow statement, by fiscal year
The statement as Simulations Plus presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF CASH FLOWS · USD thousands
| USD thousands | FY2025 Year ended Aug 31, 2025 | FY2024 Year ended Aug 31, 2024 | FY2023 Year ended Aug 31, 2023 | FY2022 Year ended Aug 31, 2022 |
|---|---|---|---|---|
| Cash flows from operating activities | ||||
| Net (loss) income | (64,718) | 9,954 | 9,961 | 12,483 |
| Adjustments to reconcile net income to net cash provided by operating activities | ||||
| Depreciation and amortization | 8,211 | 5,665 | 3,840 | 3,574 |
| Change in fair value of contingent consideration | (640) | (1,639) | 680 | 283 |
| Discharge of holdback obligation related to Immunetrics acquisition | (224) | — | — | — |
| Amortization of investment discounts | (64) | (1,116) | (1,134) | 1,678 |
| Stock-based compensation | 6,354 | 6,538 | 4,828 | 3,037 |
| Deferred income taxes | — | — | — | (270) |
| Deferred income taxes | (5,426) | (1,765) | (2,095) | — |
| Loss from disposal of assets | 23 | 0 | 6 | — |
| Impairment of other intangibles | — | 0 | 500 | — |
| Currency translation adjustments | — | (105) | 167 | (265) |
| Impairments | 77,221 | — | — | — |
| Currency translation adjustments | (25) | — | — | — |
| (Increase) decrease in | ||||
| Accounts receivable | (581) | 3,129 | 4,097 | (3,936) |
| Prepaid income taxes | 420 | (1,393) | 587 | (379) |
| Prepaid expenses and other assets | 194 | (2,143) | (501) | 1,081 |
| Increase (decrease) in | ||||
| Accounts payable | (132) | (477) | (81) | (162) |
| Other liabilities | (3,187) | (768) | 832 | (1,437) |
| Accrued income taxes | 0 | 0 | (7) | — |
| Deferred revenue | 700 | (2,560) | 176 | 2,213 |
| Net cash provided by operating activities | 18,126 | 13,320 | 21,856 | 17,900 |
| Cash flows from investing activities | ||||
| Purchases of property and equipment | (713) | (566) | (453) | (819) |
| Purchase of short-term investments | (6,500) | (67,159) | (95,045) | (100,846) |
| Proceeds from sale of short-term investments | — | — | — | 109,121 |
| Proceeds from maturities of short-term investments | 14,017 | 71,089 | 114,907 | — |
| Proceeds from sales of investments | 995 | 45,177 | — | — |
| Issuance of promissory note | (1,000) | — | — | — |
| Purchased intangibles | (379) | (541) | (601) | 0 |
| Cash received in acquisition | — | — | — | 0 |
| Business acquisition, net of cash acquired | 0 | 98,773 | (8,223) | — |
| Net working capital & excess cash settlement - Pro-ficiency acquisition | (227) | — | — | — |
| Capitalized computer software development costs | (2,631) | (3,194) | (3,219) | (3,151) |
| Net cash used in investing activities | 3,562 | (53,967) | 7,366 | 4,305 |
| Cash flows from financing activities | ||||
| Payment of dividends | 0 | (4,796) | (4,809) | (4,846) |
| Payments on contracts payable | — | — | 0 | (3,667) |
| Payments on contracts payable | (1,576) | (2,500) | — | — |
| Proceeds from the exercise of stock options | 430 | 731 | 1,543 | 891 |
| Proceeds from follow-on public offering, net | — | — | — | 0 |
| Repurchase and retirement of common shares | 0 | 0 | (20,000) | — |
| Net cash used in financing activities | (1,146) | (6,565) | (23,266) | (7,622) |
| Net (decrease) increase in cash and cash equivalents | — | (47,212) | 5,956 | 14,583 |
| Net increase (decrease) in cash and cash equivalents | 20,542 | — | — | — |
| Cash and cash equivalents, beginning of period | 10,311 | 57,523 | 51,567 | 36,984 |
| Cash and cash equivalents, end of period | 30,853 | 10,311 | 57,523 | 51,567 |
| Supplemental disclosures of cash flow information | ||||
| Income taxes paid | 1,160 | 5,689 | 3,204 | 3,233 |
| Non-Cash Investing and Financing Activities | ||||
| Stock issued for acquisition of Lixoft | — | 0 | 0 | 1,166 |
| Measurement period adjustments (See Note 2) | 956 | — | — | — |
| Creation of contract liabilities from acquisition of subsidiaries | 0 | 0 | 5,900 | 0 |
| Right of use assets capitalized | 426 | 212 | 227 | 624 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.